Advertisement

Health


Healthia board agrees to $252m buyout from Pacific Equity Partners

Healthia board agrees to $252m buyout from Pacific Equity Partners

The board of Brisbane-based allied health company Healthia (ASX: HL...

Biotech Opthea eyes $80m raise to back retinal disease therapy trials

Biotech Opthea eyes $80m raise to back retinal disease therapy trials

Melbourne-headquartered biotech company Opthea (ASX: OPT) has kicke...

Medcan Australia boosts cannabis flower production with new $12m vertical farming facility

Medcan Australia boosts cannabis flower production with new $12m vertical farming facility

Medcan Australia, a fully integrated producer of medicinal cannabis...

Vitamin delivery startup Vitable raises $7.5m and plans crowdfunded supplement

Vitamin delivery startup Vitable raises $7.5m and plans crowdfunded supplement

One of Australia's fastest-growing online vitamin brands Vitabl...

Navi raises $2.4m to develop precision med-tech for treating critically ill babies

Navi raises $2.4m to develop precision med-tech for treating critically ill babies

Melbourne-based startup Navi Medical Technologies has successfully ...

Advertisement
Advertisement
Advertisement
Medibank profit rises, CEO Craig Drummond to depart

Medibank profit rises, CEO Craig Drummond to depart

Private health insurance provider Medibank (ASX: MPL) has capital...

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Noxopharm study results herald "new era" for prostate cancer treatment

Noxopharm study results herald "new era" for prostate cancer treatment

A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...

What's the difference between mutations, variants and strains? A guide to COVID terminology

What's the difference between mutations, variants and strains? A guide to COVID terminology

Living through a global pandemic over the past year has seen all ...

Mesoblast rises on positive back pain trial results

Mesoblast rises on positive back pain trial results

Positive results from stem cell research company Mesoblast's ...

Eyes and ears on Healthia as shares double in four months

Eyes and ears on Healthia as shares double in four months

Investors appeared to take little notice of allied health group H...

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Medicinal cannabis cultivator and manufacturer Little Green Phar...

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about putti...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Advertisement

Partner Content

Social connection during times of adversity in an increasingly isol...
Investing your money early is one of the most powerful ways to secu...
SwiftFox, a Melbourne-based tech company is disrupting the CRM indu...
After declaring FY23 as a transformational year for the company, Fi...
Richard Skarzynski has been a private business owner for the past 4...
When it’s time to evolve and mature as a business, the proces...
In the ever-changing world of e-commerce, dropshipping has emerged ...
In 2023 cybercrime has its dirty little fingerprints everywhere, an...
Advertisement